Learn More
Selleck Chemical LLC Ixazomib (MLN2238) S2180-50mg

Supplier: Selleck Chemical LLC S218050MG
Ixazomib (MLN2238) inhibits the chymotrypsin-like proteolytic ( 5) site of the 20S proteasome with IC50 and Ki of 3 4 nM and 0 93 nM in cell-free assays respectively also inhibits the caspase-like ( 1) and trypsin-like ( 2) proteolytic sites with IC50 of 31 and 3500 nM Ixazomib (MLN2238) induces autophagy Phase 3
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.